These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 399929)

  • 21. [Immunological problems in oncology (author's transl)].
    Petruzzelli C; Comotti F; Pugnani M; Sacchi L; Cereser M
    Ann Sclavo; 1979; 21(4):502-44. PubMed ID: 95475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer.
    Mukherji B; Guha A; Loomis R; Ergin MT
    J Immunol; 1987 Mar; 138(6):1987-91. PubMed ID: 2950174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cellular immunity in laryngeal cancer].
    Nasretdinov TKh; Pogosov VS; Gorodilova VV; Babakova SV; Ul'chenko VM
    Vestn Otorinolaringol; 1981; (2):55-8. PubMed ID: 7013242
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunologic aspects of malignancy. II. Host immunocompetence and relationship to the clinical stage in patients with prostatic cancer.
    Ablin RJ; Guinan PD; Rios ER
    Allergol Immunopathol (Madr); 1976; 4(4):247-54. PubMed ID: 983900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monoclonal antibodies against surface antigens of cancer cells. Experimental preparation for early diagnosis and immuno-assisted therapy].
    Zenner HP
    Fortschr Med; 1983 May; 101(19):891-2, 894. PubMed ID: 6873841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunological status of laryngeal cancer patients and the problems of nonspecific immunotherapy].
    Nasretdinov TKh; Gorodilova VV; Pogosov VS; Akopian RG
    Vestn Otorinolaringol; 1981; (4):56-61. PubMed ID: 7303375
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)].
    Niksić M; Balogh M
    Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between surgery, chemotherapy, irradiation and immunological state in patients of laryngeal cancer (author's transl)].
    Krajina Z; Kosoković F; Bolanca S; Bumber Z
    Laryngol Rhinol Otol (Stuttg); 1980 Jun; 59(6):341-3. PubMed ID: 6969833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
    Miuller M; Irmsher Iu; Fisher R; Grosmann G
    Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological reactions to gliomas.
    Ridley A
    Mod Trends Neurol; 1975; 6():249-66. PubMed ID: 1105142
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immune status and HLA phenotype in 2 pairs of brothers operated on for laryngeal neoplasms].
    Banfi L; Monti G; Velonà G; Zanartonello M; Carella G
    Acta Otorhinolaryngol Ital; 1988; 8(1):11-20. PubMed ID: 3407402
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative serologic parameters of purified HL-A antigens.
    Kahan BD; Pellegrino MA; Papermaster BW; Reisfeld RA
    Transplant Proc; 1971 Mar; 3(1):227-30. PubMed ID: 4106313
    [No Abstract]   [Full Text] [Related]  

  • 34. Cell-mediated reactivity to human tumor-type associated antigens: does it exist?
    Hellström I; Hellström KE
    J Biol Response Mod; 1983; 2(4):310-20. PubMed ID: 6358420
    [No Abstract]   [Full Text] [Related]  

  • 35. [Expression and characteristics of laryngeal carcinoma-associated antigen].
    Ni Z; Sun L; Zhou J
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):205-7. PubMed ID: 11776837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the immune responsiveness in laryngeal cancer patients with specific and aspecific tests: first results of follow-up in 80 cases.
    Cortesina G; Bussi M; Morra B; Beatrice F; Cavallo GP; Di Fortunato V; Poggio E; Barioglio MG; Landolfo S; Sartoris A
    G Batteriol Virol Immunol; 1983; 76(7-12):173-86. PubMed ID: 6681017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of immunological reactivity in skin-allograft tolerating rats.
    Chutná J; Hasek M; Viklický J; Bubeník J
    Folia Biol (Praha); 1973; 19(4):252-60. PubMed ID: 4584721
    [No Abstract]   [Full Text] [Related]  

  • 38. The immune system and cancer.
    Gallucci B
    Oncol Nurs Forum; 1987; 14(6 Suppl):3-12. PubMed ID: 3320984
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
    Muhrer KH; Kahle M; Pasurka B
    Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.